Abstract
In this research we have used different cytokines and progesterone to enhance the immunomodulatory capacity of placental-derived stem cells (PLSCs) prior to their encapsulation. We assessed the effect of microencapsulation of the cells without (control) or after 3-day treatment with interferon gamma (INFγ), interleukin10 (IL-10), or progesterone (P4). Treated PLSCs demonstrated strong immunosuppressive effects on phytohemagglutinin (PHA)-activated peripheral blood mononuclear cells (PBMNCs). INFγ treatment resulted in the strongest immune inhibition among the treated groups. The treatments enhanced soluble human leukocyte antigen (sHLAG) secretion compared to control. The IL-10-treated group showed the highest effect on HLAG secretion compared to other groups. Alginate encapsulation of PLSCs did not affect cell viability, or sHLAG secretion. Also, after treatment the encapsulated PLSCs inhibited PHA-activated PBMNCs in the same manner as unencapsulated cells. We studied two groups of encapsulated PLSCs, one without perm-selective poly-l-ornithine (PLO)-coating and the other with PLO-coating, and measured levels of sHLAG secreted. We found no difference in sHLAG secretion between both groups. In summary, our data show that immunomodulatory function of the PLSC is not affected by encapsulation. These findings provide good promise for potential use of encapsulated PLSCs for immunomodulation treatment of disease by stem cell therapy.
Similar content being viewed by others
Data Availability
All data supporting the findings of this study are available from the corresponding author on reasonable request.
References
Abdi, R., P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57(7):1759–1767, 2008.
Campagnoli, C., I. A. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 98(8):2396–2402, 2001.
Carosella, E. D., P. Moreau, J. Lemaoult, and N. Rouas-Freiss. HLA-G: from biology to clinical benefits. Trends Immunol. 29(3):125–132, 2008.
Chang, C. J., M. L. Yen, Y. C. Chen, C. C. Chien, H. I. Huang, C. H. Bai, and B. L. Yen. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells. 24(11):2466–2477, 2006.
Chen, P. M., M. L. Yen, K. J. Liu, H. K. Sytwu, and B. L. Yen. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J. Biomed. Sci. 18:49, 2011.
Curigliano, G., C. Criscitiello, L. Gelao, and A. Goldhirsch. Molecular pathways: human leukocyte antigen G (HLA-G). Clin. Cancer Res. 19(20):5564–5571, 2013.
Darrabie, M. D., W. F. Kendall Jr., and E. C. Opara. Characteristics of Poly-L-Ornithine-coated alginate microcapsules. Biomaterials. 26(34):6846–6852, 2005.
de Vos, P., M. M. Faas, B. Strand, and R. Calafiore. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 27(32):5603–5617, 2006.
Diaz-Lagares, A., E. Alegre, and A. Gonzalez. Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids. Hum. Immunol. 70(12):976–980, 2009.
English, K., F. P. Barry, C. P. Field-Corbett, and B. P. Mahon. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett. 110(2):91–100, 2007.
Gebler, A., O. Zabel, and B. Seliger. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol. Med. 18(2):128–134, 2012.
Hashemi, M., and F. Kalalinia. Application of encapsulation technology in stem cell therapy. Life Sci. 143:139–146, 2015.
in’tAnker, P. S., W. A. Noort, S. A. Scherjon, C. Kleijburg-van der Keur, A. B. Kruisselbrink, R. L. van Bezooijen, W. Beekhuizen, R. Willemze, H. H. Kanhai, and W. E. Fibbe. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 88(8):845–852, 2003.
Ivanova-Todorova, E., M. Mourdjeva, D. Kyurkchiev, I. Bochev, E. Stoyanova, R. Dimitrov, T. Timeva, M. Yunakova, D. Bukarev, A. Shterev, P. Tivchev, and S. Kyurkchiev. HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am. J. Reprod. Immunol. 62(1):25–33, 2009.
Khoury, O., A. Atala, and S. V. Murphy. Stromal cells from perinatal and adult sources modulate the inflammatory immune response in vitro by decreasing Th1 cell proliferation and cytokine secretion. Stem Cells Transl. Med. 9(1):61–73, 2020.
Kim, D. S., I. K. Jang, M. W. Lee, Y. J. Ko, D. H. Lee, J. W. Lee, K. W. Sung, H. H. Koo, and K. H. Yoo. Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-gamma. EBioMedicine. 28:261–273, 2018.
Krishnamurthy, N. V., and B. Gimi. Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit. Rev. Biomed. Eng. 39(6):473–491, 2011.
Lee, K. Y., and D. J. Mooney. Alginate: properties and biomedical applications. Prog. Polym. Sci. 37(1):106–126, 2012.
Liu, K. J., C. J. Wang, C. J. Chang, H. I. Hu, P. J. Hsu, Y. C. Wu, C. H. Bai, H. K. Sytwu, and B. L. Yen. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant. 20(11–12):1721–1730, 2011.
Meier, R. P., R. Mahou, P. Morel, J. Meyer, E. Montanari, Y. D. Muller, P. Christofilopoulos, C. Wandrey, C. Gonelle-Gispert, and L. H. Buhler. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J. Hepatol. 62(3):634–641, 2015.
Meisel, R., A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 103(12):4619–4621, 2004.
Moreau, P., F. Adrian-Cabestre, C. Menier, V. Guiard, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 11(5):803–811, 1999.
Parekkadan, B., A. W. Tilles, and M. L. Yarmush. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells. 26(7):1913–1919, 2008.
Penolazzi, L., E. Tavanti, R. Vecchiatini, E. Lambertini, F. Vesce, R. Gambari, S. Mazzitelli, F. Mancuso, G. Luca, C. Nastruzzi, and R. Piva. Encapsulation of mesenchymal stem cells from Wharton’s jelly in alginate microbeads. Tissue Eng. Part C. 16(1):141–155, 2010.
Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. Multilineage potential of adult human mesenchymal stem cells. Science. 284(5411):143–147, 1999.
Rizzo, R., D. Campioni, M. Stignani, L. Melchiorri, G. P. Bagnara, L. Bonsi, F. Alviano, G. Lanzoni, S. Moretti, A. Cuneo, F. Lanza, and O. R. Baricordi. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy. 10(4):364–375, 2008.
Rouas-Freiss, N., R. M. Goncalves, C. Menier, J. Dausset, and E. D. Carosella. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA. 94(21):11520–11525, 1997.
Selmani, Z., A. Naji, E. Gaiffe, L. Obert, P. Tiberghien, N. Rouas-Freiss, E. D. Carosella, and F. Deschaseaux. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation. 87(9 Suppl):S62–S66, 2009.
Selmani, Z., A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, N. Rouas-Freiss, E. D. Carosella, and F. Deschaseaux. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells. 26(1):212–222, 2008.
Tendulkar, S., J. P. McQuilling, C. Childers, R. Pareta, E. C. Opara, and M. K. Ramasubramanian. A scalable microfluidic device for the mass production of microencapsulated islets. Transplant Proc. 43(9):3184–3187, 2011.
Toma, J. G., M. Akhavan, K. J. Fernandes, F. Barnabe-Heider, A. Sadikot, D. R. Kaplan, and F. D. Miller. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3(9):778–784, 2001.
Trouche, E., S. Girod Fullana, C. Mias, C. Ceccaldi, F. Tortosa, M. H. Seguelas, D. Calise, A. Parini, D. Cussac, and B. Sallerin. Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ. Cell Transplant. 19(12):1623–1633, 2010.
Yang, S. H., M. J. Park, I. H. Yoon, S. Y. Kim, S. H. Hong, J. Y. Shin, H. Y. Nam, Y. H. Kim, B. Kim, and C. G. Park. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp. Mol. Med. 41(5):315–324, 2009.
Yu, J., K. T. Du, Q. Fang, Y. Gu, S. S. Mihardja, R. E. Sievers, J. C. Wu, and R. J. Lee. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials. 31(27):7012–7020, 2010.
Acknowledgments
The authors would like to thank Dr. Sean Murphy Lab at WFIRM for the provision of the placenta mesenchymal stem cells used in our studies.
Funding
This work was supported in part with funds from a scholarship from the Egyptian government to Fatma Khalil as a part of a joint research training supervision agreement with the Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest regarding this study.
Ethical Approval and Consent to Participate
All human cells, peripheral blood mononuclear cells (PBMNCs), and placental stem cells (PLSCs) used in this study were obtained in accordance with the Declaration of Helsinki under protocols approved by the Wake Forest University Sciences Institutional Review Board (IRB).
Consent for Publication
Not applicable as no images, or videos relating to an individual person is included in this manuscript.
Additional information
Associate Editor Joel D. Stitzel oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khalil, F., Alwan, A., Ralph, P. et al. Effect of Alginate Microbead Encapsulation of Placental Mesenchymal Stem Cells on Their Immunomodulatory Function. Ann Biomed Eng 50, 291–302 (2022). https://doi.org/10.1007/s10439-022-02920-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-022-02920-5